Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6)

Abstract

Cyclin-dependent kinase 6(cdk6) is present in randomly proliferating cultures of 3T3 cells but has little detectable enzymatic activity. Significant activity is detected only during a short period in early G1 phase. To examine the possible functions of cdk6 in 3T3 cells, lines stably over-expressing cdk6 were constructed and compared to normal 3T3 cells or cell lines with reduced cdk6 levels due to expression of a dominant-negative form of the protein. Over-expression of cdk6 in cells, which led to high levels of activity even in proliferating cultures, had dramatic effects. Cell lines stably over-expressing wild-type cdk6 had a markedly reduced growth rate compared to parental 3T3 cells or lines expressing a dominant-negative form of cdk6. They also over-produced the p53 and p130 proteins and had increased sensitivity to UV-irradiation. Irradiation resulted in accumulation of the Bax protein and rapid cell death. Levels of p53 and p130 proteins were down-regulated and the growth rate of the cells was increased by introduction of the dominant-negative form of cdk6 into cells over-expressing cdk6, indicating that cdk6 is involved in the overproduction of p53 and p130. The results suggest that cdk6, through regulation of growth-suppressing molecules, may play a role in halting cellular growth when proliferation is inappropriate.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 12
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 13
Figure 14

Similar content being viewed by others

References

  • Bagella L, MacLachlan TK, Buono RJ, Pisano MM, Giordano A, De Luca A . 1998 J. Cell. Physiol. 177: 206–213

  • Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G . 1994 Oncogene 9: 71–79

  • De Falco G, Giordano A . 1998 J. Cell. Physiol. 177: 501–506

  • De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A . 1997 J. Biol. Chem. 272: 20971–20974

  • Dong F, Cress WD, Agrawal D, Pledger WJ . 1998 J. Biol. Chem. 273: 6190–6195

  • Edwards MC, Wong C, Elledge SJ . 1998 Mol. Cell. Biol. 18: 4291–4300

  • El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Feaver WJ, Svejstrup JQ, Henry NL, Kornberg RD . 1994 Cell 79: 1103–1109

  • Fisher RP, Morgan DO . 1994 Cell 78: 713–724

  • Fujinaga K, Cujec TP, Peng J, Garriga J, Price DH, Grana X, Peterlin BM . 1998 J. Virol. 72: 7154–7159

  • Garriga J, Limon A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andres V, Grana X . 1998 Biochem. J. 333: 645–654

  • Grossel MJ, Baker GL, Hinds PW . 1999 J. Biol. Chem. 274: 29960–29967

  • Haapajarvi T, Pitkanen K, Tsubari M, Laiho M . 1997 Mol. Cell. Biol. 17: 3074–3080

  • Hanks SK . 1987 Proc. Natl. Acad. Sci. USA 84: 388–392

  • Hengstschlager M, Braun K, Soucek T, Miloloza A, Hengstschlager-Ottnad E . 1999 Mutat. Res. 436: 1–9

  • Hiyami H, Iavarone A, LaBaer J, Reeves SA . 1997 Oncogene 14: 2533–2542

  • Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM, Caputi M, Khalili K, Giordano A . 2000 Cancer Res. 60: 2737–2744

  • Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL . 2000 Blood 96: 2746–2754

  • Jiang H, Chou HS, Zhu L . 1998 Mol. Cell. Biol. 18: 5284–5290

  • Kapoor M, Lozano G . 1998 Proc. Natl. Acad. Sci. USA 95: 2834–2837

  • Ko LJ, Prives C . 1996 Genes Develop. 10: 1054–1072

  • Koh J, Enders GH, Dynlacht BD, Harlow E . 1995 Nature 375: 506–510

  • Lazebnik YA, Kaufmann SH, Desnoyers S, Poirer GG, Earnshaw WC . 1994 Nature 371: 346–357

  • LeCouter JE, Whyte PF, Rudnicki MA . 1996 Oncogene 12: 1433–1440

  • Levine AJ . 1997 Cell 88: 323–331

  • Lu X, Lane DP . 1993 Cell 75: 765–778

  • Lucas JJ, Szepesi A, Domenico J, Takase K, Tordai A, Terada N, Gelfand EW . 1995b J. Cell. Physiol. 165: 406–416

  • Lucas JJ, Szepesi A, Domenico J, Tordai A, Terada N, Gelfand EW . 1995c Blood 86: 2268–2280

  • Lucas JJ, Szepesi A, Modiano JF, Domenico J, Gelfand EW . 1995a J. Immunol. 154: 6275–6284

  • Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J . 1995 Nature 375: 503–506

  • MacLachlan TK, Sang N, De Luca A, Puri PL, Levrero M, Giordano A . 1998 J. Cell. Biochem. 71: 467–478

  • Martinez JD, Craven MT, Joseloff E, Milczarek G, Bowden GT . 1997 Oncogene 14: 2511–2520

  • Matsushime H, Roussel MF, Ashmun RA, Sherr CJ . 1991 Cell 65: 701–713

  • Matsushime H, Quelle De, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y . 1994 Mol. Cell. Biol. 14: 2066–2076

  • Matushansky I, Radparvar F, Skoultchi A . 2000a Blood 96: 2755–2764

  • Matushansky I, Radparvar F, Skoultchi AI . 2000b Proc. Natl. Acad. Sci. USA 97: 14317–14322

  • Mayol X, Garriga J, Grana X . 1995 Oncogene 11: 801–808

  • Mayol X, Garriga J, Grana X . 1996 Oncogene 13: 237–246

  • Mayol X, Grana X . 1998 Frontiers Biosci. 3: 11–24

  • Medema RH, Herrera Re, Lam F, Weinberg RA . 1995 Proc. Natl. Acad. Sci. USA 92: 6289–6293

  • Mercer WE, Baserga R . 1985 Exp. Cell Res. 160: 31–46

  • Meyerson M, Enders GH, Wu C-L, Su L-K, Gorka C, Nelson C, Harlow E, Tsai L-H . 1992 EMBO J. 11: 2909–2917

  • Meyerson M, Harlow E . 1994 Mol. Cell. Biol. 14: 2077–2086

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Moberg K, Starz MA, Lees JA . 1996 Mol. Cell. Biol. 16: 1436–1449

  • Nagasawa M, Melamed I, Kupfer A, Gelfand EW, Lucas JJ . 1997 J. Immunol. 158: 5146–5154

  • Nigg EA . 1993 Curr. Opin. Cell Biol. 5: 187–193

  • Ojala PM, Tianen M, Salven P, Veikkola T, Castanos-Velez E, Sarid R, Biberfeld P, Makela TP . 1999 Cancer Res. 59: 4984–4989

  • Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP . 2000 Nature Cell Biol. 2: 819–825

  • Oltvai ZN, Millman CL, Korsmeyer SJ . 1993 Cell 74: 609–619

  • Pines J . 1994 Semin. Cell Biol. 5: 339–408

  • Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M . 1999 Nature Genetics 22: 44–52

  • Pines J, Hunter T . 1990 New Biol. 2: 389–401

  • Reich NC, Oren M, Levine AJ . 1983 Mol. Cell. Biol. 3: 2143–2150

  • Rickert P, Seghezzi W, Shanahan F, Lees E . 1996 Oncogene 12: 2631–2640

  • Sergere JC, Thuret JY, Le G, Edgardo R, Carosella D, Leteurte F . 2000 Biochem. Biophys. Res. Commun. 16: 271–277

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sherr CJ, Roberts JM . 1995 Genes Develop. 9: 1149–1163

  • Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR . 1996 Mol. Cell. Biol. 16: 6965–6976

  • Smith EJ, Leone G, Nevins JR . 1998 Cell Growth Diff. 9: 297–303

  • Solomon MJ, Harper JW, Shuttleworth . 1993 EMBO J. 12: 3133–3142

  • Szepesi A, Gelfand EW, Lucas JJ . 1994 Blood 84: 3413–3421

  • Tang D, Wang JH . 1996 Progr. Cell Cycle Res. 2: 205–216

  • Tassan J-P, Jacquenoud M, Leopold P, Schultz SJ, Nigg EA . 1995 Proc. Natl. Acad. Sci. USA 92: 8871–8875

  • Terada N, Lucas JJ, Gelfand EW . 1991 J. Immunol. 147: 698–704

  • Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW . 1993 J. Cell. Physiol. 154: 7–15

  • Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM . 1995 Cell 81: 801–809

  • Todaro GJ, Green H . 1963 J. Cell Biol. 17: 299–313

  • Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, Koyokawa H . 1999 Mol. Cell. Biol. 19: 7011–7019

  • van den Heuvel S, Harlow E . 1993 Science 262: 2050–2054

  • Wei P, Garber ME, Fang SM, Fischer WH, Jones KA . 1998 Cell 92: 451–462

  • Weinberg RA . 1995 Cell 81: 323–330

  • White E . 1996 Genes Develop. 10: 1–15

  • Winston JT, Pledger WJ . 1993 Mol. Biol. Cell. 4: 1133–1144

  • Won K, Xiong Y, Beach D, Gilman MZ . 1992 Proc. Natl. Acad. Sci. USA 89: 9910–9914

  • Zhang Q, Ahuya HS, Zakeri ZF, Wolgemuth DJ . 1997 Develop. Biol. 183: 222–233

Download references

Acknowledgements

We thank Joanne Hahn and Joseph S Lucas for expert technical assistance and helpful discussions. This research was supported in part by American Cancer Society Grant IM-746 (to JJ Lucas), by grants from the Denver Metropolitan Chapter of the Susan G Komen Breast Cancer Foundation and the Cancer League of Colorado (to JJ Lucas), by grants from the National Institute of Health HL-36577 and AI-42246 (EW Gelfand) and by the University of Colorado Cancer Center Core Grant CA46934.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagasawa, M., Gelfand, E. & Lucas, J. Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6). Oncogene 20, 2889–2899 (2001). https://doi.org/10.1038/sj.onc.1204396

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204396

Keywords

This article is cited by

Search

Quick links